Medtronic Plc

NYSE:MDT   3:59:58 PM EDT
-1.04 (-0.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)144.55B
Current PE30.55
Forward PE 18.89
2yr Forward PE 17.42
See more stats
Estimates Current Quarter
Revenue$7.94 Billion
Adjusted EPS$1.37
See more estimates
10-Day MA$107.12
50-Day MA$109.67
200-Day MA$121.48
See more pivots

Medtronic Plc Stock, NYSE:MDT

20 On Hatch, Lower Hatch Street, Dublin, Dublin 2
United States of America
Phone: +353.1.438.1700
Number of Employees: 90000


Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consists of products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Minimally Invasive Technologies Group segment focuses on respiratory system, gastrointestinal tract, renal system, lungs, pelvic region, kidneys, and obesity diseases. The Restorative Therapies Group segment comprises of neurostimulation therapies and drug delivery systems for the treatment of chronic pain, as well as areas of the spine and brain, along with pelvic health and conditions of the ear, nose, and throat. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.